CurePSP Pathway and Pipeline Grants

Research Grants

CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP and CBD at pre-clinical and clinical levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP, CBD, and other prime of life diseases.

CurePSP will fund studies on PSP and CBD with a particular interest in (i) fundamental neurobiology and mechanisms of PSP and CBD and (ii) translational projects focusing on new therapeutics and biomarkers for PSP and CBD.

CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.

CurePSP Research Focus for 2023



Research Grant Application

CurePSP accepts proposals for research projects from academic and non-academic institutions. The CurePSP Scientific Advisory Board reviews all submissions and recommends the most appropriate projects for funding. The next grant deadline is October 31, 2023, at 5pm ET. Grants will be submitted to ProposalCentral. Grant instructions can be found here

The maximum total grant amount awarded is $100,000. The period of the grant may be up to 2 years in duration but the total cannot exceed $100,000. However, greater or lesser amounts and duration may be offered depending on resources available. Any investigators interested in submitting a grant application should first review CurePSP’s Research Policies and Procedures.

For questions regarding the peer-review process, scientific aspects of the grant application and grants administration or finances, please contact Dr. Jennifer Brummet at